CONOR BARRY
VP Piramal Pharma Solutions
Seminars
Tuesday 13th October 2026
Evaluating Phase & Product Appropriate Bioconjugate Development
11:30 am
- Exploring the differing development approaches of ADCs across the preclinical to commercial spectrum
- Understanding how the bioconjugate landscape now encompasses a wide variety of modalities with differing MoAs and molecular structures
- Exploring relevant examples of how the requirements for process and analytical development can vary between different conjugates
